Takayoshi Shimohata

Title: Takayoshi Shimohata: Innovator in Cell Preparation and Ischemic Treatment

Introduction

Takayoshi Shimohata is a prominent inventor based in Niigata, Japan. He has made significant contributions to the field of biomedical research, particularly in the development of methods for cell preparation and treatments for ischemic conditions. With a total of three patents to his name, Shimohata's work is focused on advancing medical therapies for serious health issues.

Latest Patents

One of Shimohata's latest patents is titled "Cell preparation and method for producing cell preparation." This invention provides a method for producing a cell culture that promotes angiogenesis or axon outgrowth. It is particularly aimed at treating cerebrovascular diseases, ischemic cardiac diseases, traumatic brain injuries, and spinal cord injuries. The method involves culturing a cell population containing microglia and/or monocytes under conditions of low oxygen and/or low sugar concentration. The resulting cell preparation can be used in therapeutic applications for various ischemic conditions.

Another significant patent is the "Pharmaceutical composition for treating ischemic events." This patent discloses methods and pharmaceutical compositions designed to treat severe ischemic events, including cerebral infarction, cardiac infarction, and pulmonary embolism. The treatment involves a thrombolytic intervention that includes thrombolytic agents and an inhibitor of vascular endothelial growth factor (VEGF) receptor-mediated signal transduction.

Career Highlights

Throughout his career, Takayoshi Shimohata has worked with esteemed institutions such as Niigata University and the Foundation for Biomedical Research and Innovation at Kobe. His research has focused on innovative solutions to complex medical challenges, particularly in the realm of ischemic diseases.

Collaborations

Shimohata has collaborated with notable professionals in his field, including Lawrence M. Kauvar and Masato Kanazawa. These collaborations have contributed to the advancement of his research and the development of his patented technologies.

Conclusion

Takayoshi Shimohata is a distinguished inventor whose work in cell preparation and ischemic treatment has the potential to significantly impact medical science. His innovative patents reflect a commitment to improving health outcomes for patients suffering from serious conditions.